Umer Raffat
Stock Analyst at Evercore ISI
(4.08)
# 1,690
Out of 4,630 analysts
161
Total ratings
52.1%
Success rate
9.5%
Average return
Main Sectors:
Stocks Rated by Umer Raffat
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Hold | n/a | $1,185.71 | - | 14 | Aug 6, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | n/a | $133.21 | - | 16 | Aug 5, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | n/a | $34.98 | - | 1 | Jul 6, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | n/a | $104.91 | - | 6 | Jun 3, 2026 | |
| PCVX Vaxcyte | Maintained: Buy | n/a | $58.07 | - | 2 | May 21, 2026 | |
| BIIB Biogen | Initiated Coverage: Buy | n/a | $207.94 | - | 8 | May 15, 2026 | |
| KLRA Kailera Therapeutics | Initiated Coverage: Buy | n/a | $18.66 | - | 1 | May 12, 2026 | |
| ELAN Elanco Animal Health | Maintained: Buy | n/a | $22.12 | - | 6 | May 11, 2026 | |
| AMGN Amgen | Maintained: Buy | n/a | $410.95 | - | 17 | May 1, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | n/a | $8.70 | - | 6 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $26.76 | - | 8 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.60 | - | 7 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $45.37 | - | 3 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $5.25 | +90.48% | 3 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $56.77 | - | 3 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $35.36 | - | 9 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $49.17 | - | 6 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $27.35 | - | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $28.62 | - | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.6996 | - | 2 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $23.67 | n/a | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.76 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $128.58 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $16.78 | n/a | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $22.82 | n/a | 4 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $8.55 | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $20.75 | n/a | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.43 | n/a | 6 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $256.56 | n/a | 5 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $157.77 | n/a | 3 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.04 | n/a | 2 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $23.59 | n/a | 1 | Mar 9, 2018 |
Eli Lilly and Company
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $1,185.71
Upside: -
Gilead Sciences
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $133.21
Upside: -
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $34.98
Upside: -
Spyre Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $104.91
Upside: -
Vaxcyte
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $58.07
Upside: -
Biogen
May 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $207.94
Upside: -
Kailera Therapeutics
May 12, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $18.66
Upside: -
Elanco Animal Health
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $22.12
Upside: -
Amgen
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $410.95
Upside: -
Bausch Health Companies Inc.
Apr 30, 2026
Maintained: Hold
Price Target: n/a
Current: $8.70
Upside: -
Apr 27, 2026
Maintained: Buy
Price Target: n/a
Current: $26.76
Upside: -
Apr 10, 2026
Maintained: Hold
Price Target: n/a
Current: $13.60
Upside: -
Mar 27, 2026
Maintained: Buy
Price Target: n/a
Current: $45.37
Upside: -
Mar 9, 2026
Maintained: Buy
Price Target: $10
Current: $5.25
Upside: +90.48%
Feb 12, 2026
Maintained: Hold
Price Target: n/a
Current: $56.77
Upside: -
Nov 26, 2025
Maintained: Buy
Price Target: n/a
Current: $35.36
Upside: -
Nov 12, 2025
Maintained: Buy
Price Target: n/a
Current: $49.17
Upside: -
Nov 11, 2025
Maintained: Buy
Price Target: n/a
Current: $27.35
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: n/a
Current: $28.62
Upside: -
Sep 30, 2025
Maintained: Buy
Price Target: n/a
Current: $0.6996
Upside: -
May 12, 2025
Maintained: Buy
Price Target: n/a
Current: $23.67
Upside: n/a
Feb 21, 2025
Maintained: Buy
Price Target: n/a
Current: $8.76
Upside: n/a
Feb 5, 2025
Maintained: Buy
Price Target: n/a
Current: $128.58
Upside: n/a
Oct 15, 2024
Upgraded: Buy
Price Target: n/a
Current: $16.78
Upside: n/a
Mar 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $22.82
Upside: n/a
May 11, 2023
Upgraded: Buy
Price Target: n/a
Current: $8.55
Upside: n/a
Nov 1, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $20.75
Upside: n/a
Dec 9, 2021
Maintained: Buy
Price Target: n/a
Current: $16.43
Upside: n/a
Jan 28, 2021
Maintained: Buy
Price Target: n/a
Current: $256.56
Upside: n/a
Jul 20, 2020
Reiterated: Buy
Price Target: n/a
Current: $157.77
Upside: n/a
Jun 4, 2019
Maintained: Buy
Price Target: n/a
Current: $4.04
Upside: n/a
Mar 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $23.59
Upside: n/a